| P2093 | author name string | M Landry | |
| | Y Perel | |
| | E Dobremez | |
| | J Rivel | |
| | L Amrein | |
| | J Y Daniel | |
| P2860 | cites work | Molecular characterization and expression of cloned human galanin receptors GALR2 and GALR3 | Q22008499 |
| | Molecular cloning of a functional human galanin receptor | Q24306226 |
| | Sequence of human galanin and its inhibition of glucose-stimulated insulin secretion from RIN cells | Q24338383 |
| | Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee | Q28140516 |
| | Ontogeny of peptide- and amine-containing neurones in motor, sensory, and autonomic regions of rat and human spinal cord, dorsal root ganglia, and rat skin | Q28306810 |
| | NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology | Q33501051 |
| | Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group | Q33876841 |
| | Targeted expression of MYCN causes neuroblastoma in transgenic mice | Q33886720 |
| | Autocrine and paracrine signaling through neuropeptide receptors in human cancer | Q34225976 |
| | G-protein-coupled receptors and signaling networks: emerging paradigms. | Q34296103 |
| | Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. | Q34351596 |
| | Growth of small cell lung cancer cells: stimulation by multiple neuropeptides and inhibition by broad spectrum antagonists in vitro and in vivo | Q35227133 |
| | Targeted disruption of the galanin gene reduces the number of sensory neurons and their regenerative capacity | Q35320080 |
| | Galanin regulates the postnatal survival of a subset of basal forebrain cholinergic neurons | Q35320973 |
| | Limited neuropeptide Y precursor processing in unfavourable metastatic neuroblastoma tumours | Q36621739 |
| | Expression of galanin and a galanin receptor in several sensory systems and bone anlage of rat embryos | Q37056101 |
| | Galanin-R1 and -R2 receptor mRNA expression during the development of rat brain suggests differential subtype involvement in synaptic transmission and plasticity | Q38308638 |
| | Galanin--a neuroendocrine peptide | Q40491500 |
| | Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells | Q40881080 |
| | Determination of ligand binding affinities for endogenous seven-transmembrane receptors using fluorometric microvolume assay technology | Q40940564 |
| | Neuropeptides in neuroblastomas and ganglioneuromas. | Q40940927 |
| | Regulation of neuropeptide expression in sympathetic neurons. Paracrine and retrograde influences | Q41478958 |
| | Sensitive mRNA detection using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistry | Q41858740 |
| | Galanin is released by adrenocorticotropin-secreting pituitary adenomas in vivo and in vitro | Q42470460 |
| | Galanin and galanin receptor expression in neuroblastoma | Q48294842 |
| | Galanin is a paracrine inhibitor of gonadotroph function in the female rat. | Q48387757 |
| | Role of neurotrophins and their receptors in human neuroblastomas: a primary culture study | Q48502478 |
| | Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin- and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus | Q48563173 |
| | Developmental expression of galanin-like immunoreactivity by members of the avian sympathoadrenal cell lineage. | Q52179895 |
| | Development of galanin- and enkephalin-like immunoreactivities in the sympathoadrenal lineage of the avian embryo. In vivo and in vitro studies. | Q52197295 |
| | Somatostatin receptor gene expression in neuroblastoma. | Q54179363 |
| | N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique | Q60035759 |
| | D1 and D2 dopamine receptor gene expression in the rat striatum: Sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAS in distinct neuronal populations of the dorsal and ventral striatum | Q61762612 |
| | Genetic Staging of Unresectable or Metastatic Neuroblastomain Infants: a Pediatric Oncology Group Study | Q63641179 |
| | Galanin immunoreactivity in neuroendocrine tumors | Q67702230 |
| | Nonradioactive labeling of oligonucleotides in vitro with the hapten digoxigenin by tailing with terminal transferase | Q70185224 |
| | Somatostatin, galanin and peptide histidine isoleucine in the newborn and adult human trigeminal ganglion and spinal nucleus: immunohistochemistry, neuronal morphometry and colocalization with substance P | Q71672489 |
| | Galanin receptors from human pituitary tumors assayed with human galanin as ligand | Q72106173 |
| | Effect of axotomy on expression of NPY, galanin, and NPY Y1 and Y2 receptors in dorsal root ganglia and the superior cervical ganglion studied with double-labeling in situ hybridization and immunohistochemistry | Q73598398 |
| | The somatostatin analogue octreotide inhibits neuroblastoma growth in vivo | Q78206758 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 117-122 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Galanin and galanin receptor expression in neuroblastic tumours: correlation with their differentiation status | |
| P478 | volume | 86 | |